Search Within

Andrew D Seidman

Formats
  1. Journal Article (175)
  2. Meeting Abstract (123)
  3. Conference Paper (9)
  4. Correspondence (3)
  5. Review (3)
  6. Book Section (2)
  7. Research Letter (2)
  8. Editorial (1)
Groups
  1. Breast Medicine Service (318)
  2. Department of Medicine (318)
  3. Solid Tumor Oncology Division (318)
  4. Survivorship Research (158)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (116)
  6. Epidemiology and Biostatistics (84)

More Groups

People
  1. Clifford Hudis (116)
  2. Larry Norton (99)
  3. Teresa Gilewski (38)
  4. Monica Fornier (37)
  5. Gabriella D'Andrea-Carlino (36)
  6. Violante Currie (32)

More People

Years
  1. 2025 (3)
  2. 2024 (4)
  3. 2023 (10)
  4. 2022 (6)
  5. 2021 (9)
  6. 2020 (6)

More Years

Publications
  1. Journal of Clinical Oncology (83)
  2. Breast Cancer Research and Treatment (25)
  3. Cancer Research (23)
  4. Clinical Breast Cancer (19)
  5. Seminars in Oncology (16)
  6. Oncology (Norwalk) (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (84)
  2. Elsevier Inc. (55)
  3. Springer (40)
  4. American Association for Cancer Research (36)
  5. Oxford University Press (29)
  6. C M P Medica LLC * The Oncology Group (14)

More Publishers

Results (318)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy
    Journal Article

    Hurria, A.; Zuckerman, E.; Panageas, K. S.; Fornier, M.; D'Andrea, G.; Dang, C.; Moasser, M.; Robson, M.; Seidman, A.; Currie, V.; more...
    Journal of the American Geriatrics Society (2006)

    Fulltext@MSK | Save
  • Serum HER2 extracellular domain (ECD) levels and efficacy of weekly (W) or every 3-weekly (q3W) paclitaxel (P) with or without trastuzumab (T) in patients (pts) with metastatic breast cancer (MBC): CALGB 150002/9840
    Meeting Abstract

    Seidman, A. D.; Broadwater, G.; Carney, W.; Dressler, L.; Berry, D.; Norton, L.; Hudis, C.; Winer, E.; Ellis, M.; Harris, L.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Understanding racial differences in outcome from metastatic breast cancer (MBC): A pooled analysis of Cancer and Leukemia Group B (CALGB) 9342 and 9840
    Meeting Abstract

    Polite, B. N.; Cirrincione, C.; Fleming, G. F.; Berry, D. A.; Seidman, A. D.; Muss, H.; Norton, L.; Hudis, C.; Winer, E. P.
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Impact of HER2 status in breast cancer patients receiving stereotactic radiosurgery for brain metastases
    Meeting Abstract

    O'meara, W. P.; Seidman, A. D.; Yamada, Y.; McCormick, B.; Diamond, S.; Gutin, P. H.; Narayana, A.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • A prospective longitudinal study of the impact of adjuvant chemotherapy for breast cancer (BC) on older patients' functional status and quality of life
    Meeting Abstract

    Hurria, A.; Panageas, K.; Zuckerman, E.; Fornier, M.; D'Andrea, G.; Dang, C.; Moasser, M.; Robson, M.; Seidman, A.; Currie, V.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Increased dose-density (DD) is feasible: A pilot study of epirubicin and cyclophosphamide (EC) followed by paclitaxel (T), at 10-11 day interval with filgrastim support, for women with early breast carcinoma (BC)
    Meeting Abstract

    Fornier, M. N.; Seidman, A. D.; Lake, D.; D'Andrea, G.; Bromberg, J.; Robson, M.; Van Poznak, C. H.; Panageas, K.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Prolonged dose-dense (DD) epirubicin and cyclophosphamide (EC) followed by paclitaxel (T) in breast cancer (BCA) is feasible
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Preliminary cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Pilot trial of trastuzumab starting with or after the doxorubicin component of a doxorubicin plus paclitaxel regimen for women with HER2-positive advanced breast cancer
    Journal Article

    Seidman, A. D.
    Breast Diseases: A Year Book Quarterly (2005)

    Fulltext@MSK | Save
  • Multicenter randomized phase III trial of epirubicin plus paclitaxel vs epirubicin followed by paclitaxel in metastatic breast cancer patients: Focus on cardiac safety
    Journal Article

    Seidman, A. D.
    Breast Diseases: A Year Book Quarterly (2005)

    Fulltext@MSK | Save